These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35664324)

  • 21.
    Gao Y; Li Y; Song Z; Jin Z; Li X; Yuan C
    J Oncol; 2022; 2022():6509028. PubMed ID: 35847356
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    He T; Xu B; Ma H
    Transl Cancer Res; 2024 Jul; 13(7):3729-3741. PubMed ID: 39145094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycolysis-related gene dihydrolipoamide acetyltransferase promotes poor prognosis in hepatocellular carcinoma through the Wnt/β-catenin and PI3K/Akt signaling pathways.
    Zhou Y; Gu H; Shao B; Zhang S; Pall H; Peixoto RD; Mok SRS; Zhu G
    Ann Transl Med; 2022 Nov; 10(22):1240. PubMed ID: 36544660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COPB2: A Novel Prognostic Biomarker That Affects Progression of HCC.
    Zhang J; Wang X; Li G; He J; Lu Z; Yang Y; Jiang Y; Jiang L; Li F; Liu J
    Biomed Res Int; 2021; 2021():6648078. PubMed ID: 33824874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.
    Ma C; Kang W; Yu L; Yang Z; Ding T
    Front Oncol; 2020; 10():590006. PubMed ID: 33363020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
    Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
    Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
    [No Abstract]   [Full Text] [Related]  

  • 27. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
    Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
    Gene; 2019 May; 698():9-18. PubMed ID: 30825595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD69 serves as a potential diagnostic and prognostic biomarker for hepatocellular carcinoma.
    Tang K; Li X; Mo J; Chen Y; Huang C; Li T; Luo T; Zhong Z; Jiang Y; Yang D; Mo W
    Sci Rep; 2023 May; 13(1):7452. PubMed ID: 37156819
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Wei Y; Lan C; Wang X; Zhou X; Liao X; Huang H; Wei Z; Li T; Peng T; Zhu G
    Int J Gen Med; 2023; 16():4377-4392. PubMed ID: 37789880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel prognostic index of hepatocellular carcinoma based on immunogenomic landscape analysis.
    Xiao H; Wang B; Xiong HX; Guan JF; Wang J; Tan T; Lin K; Zou SB; Hu ZG; Wang K
    J Cell Physiol; 2021 Apr; 236(4):2572-2591. PubMed ID: 32853412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishment of a Prognostic Model for Hepatocellular Carcinoma Based on Endoplasmic Reticulum Stress-Related Gene Analysis.
    Liu P; Wei J; Mao F; Xin Z; Duan H; Du Y; Wang X; Li Z; Qian J; Yao J
    Front Oncol; 2021; 11():641487. PubMed ID: 34094926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High Expression of TGF-β1 Contributes to Hepatocellular Carcinoma Prognosis
    Jin X; Zhang S; Wang N; Guan L; Shao C; Lin Y; Liu J; Li Y
    Front Oncol; 2022; 12():861601. PubMed ID: 35547872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening of Candidate Inflammatory Markers of Epithelial Cells in Hepatocellular Carcinoma Based on Integration Analysis of TCGA/ICGC Databases and Single-cell Sequencing.
    Huang Z; Li Z; Lv X; Tan W
    Recent Pat Anticancer Drug Discov; 2024 Jan; ():. PubMed ID: 38299418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FBXO17 promotes malignant progression of hepatocellular carcinoma by activating wnt/β-catenin pathway.
    Liu FH; Cui YP; He YK; Shu RH
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8265-8273. PubMed ID: 31646557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PORCN promotes hepatocellular carcinogenesis via Wnt/β-catenin-dependent manner.
    Wu S; Liu Z; Chen J; Ma T; Wang L; Huang T; Sheng Y; Huang W; Lu C
    Transl Cancer Res; 2023 Jul; 12(7):1703-1714. PubMed ID: 37588740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NAP1L1 Promotes Endometrial Cancer Progression via EP300-Mediated DDX5 Promoter Acetylation.
    Zhu X; Li Y; Shao Z; Lu X; Chen Y
    Mol Cancer Res; 2024 Nov; 22(11):1011-1021. PubMed ID: 38953887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of DTL in Hepatocellular Carcinoma and Its Impact on the Tumor Microenvironment.
    Li Z; Wang R; Qiu C; Cao C; Zhang J; Ge J; Shi Y
    Front Immunol; 2022; 13():834606. PubMed ID: 35392073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bromodomain-containing protein 9 promotes hepatocellular carcinoma progression via activating the Wnt/β-catenin signaling pathway.
    Fang D; Wang MR; Guan JL; Han YY; Sheng JQ; Tian DA; Li PY
    Exp Cell Res; 2021 Sep; 406(2):112727. PubMed ID: 34370992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of CDC20 as an immune infiltration-correlated prognostic biomarker in hepatocellular carcinoma.
    Xiong C; Wang Z; Wang G; Zhang C; Jin S; Jiang G; Bai D
    Invest New Drugs; 2021 Oct; 39(5):1439-1453. PubMed ID: 33942202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis.
    Yan Z; He M; He L; Wei L; Zhang Y
    Front Immunol; 2021; 12():723271. PubMed ID: 34925311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.